Exicure, Inc. (NASDAQ:XCUR) Short Interest Down 52.4% in August

Exicure, Inc. (NASDAQ:XCUR) was the recipient of a significant decline in short interest in the month of August. As of August 15th, there was short interest totaling 26,000 shares, adeclineof52.4% from the July 31st total of 54,600 shares. Approximately1.4% of the company’s shares are short sold. Based on an average daily volume of 113,200 shares, the days-to-cover ratio is currently 0.2 days. Based on an average daily volume of 113,200 shares, the days-to-cover ratio is currently 0.2 days. Approximately1.4% of the company’s shares are short sold.

Exicure Stock Performance

Shares of NASDAQ XCUR opened at $4.75 on Friday. The stock has a market cap of $30.02 million, a P/E ratio of -1.22 and a beta of 3.84. The firm has a 50 day moving average price of $6.76 and a 200 day moving average price of $9.23. Exicure has a 52-week low of $1.44 and a 52-week high of $36.00.

Exicure (NASDAQ:XCUR) last issued its quarterly earnings data on Friday, August 8th. The company reported ($0.41) earnings per share (EPS) for the quarter.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.